GlassScriptPhysician profile
Erica Pargmann
NPI 1063172971
$723.33
in general payments reported to CMS, 2019-2025
13 companies · $45.46 in 2025
The $45.46 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.57 · 2022: $290 · 2023: $228 · 2024: $116 · 2025: $45.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $389.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $279.34 | 2022-2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $69.68 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $68.18 | 2022 | |
| Corium, LLC | $65.31 | 2024-2025 | Azstarys |
| Vertical Pharmaceuticals, LLC | $59.84 | 2024 | Relexxii |
| Supernus Pharmaceuticals, INC. | $47.62 | 2022 | |
| Orexo US, INC. | $26.09 | 2021 | |
| Ironshore Pharmaceuticals INC. | $22.45 | 2024 | |
| Janssen Pharmaceuticals, INC | $21.91 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $19.34 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.32 | 2022 | |
| Collegium Pharmaceutical, INC. | $13.77 | 2025 | Jornay Pm |
| Avion Pharmaceuticals | $13.48 | 2023 | Methylphenidate Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erica Pargmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.